Professor Emmanuel Alhassan
At Sabo market in Kaduna, 47-year-old Yusuf Ibrahim, a schoolteacher and father of four, slumped beside a pile of grain. He never woke up. To his heartbroken family, it was a sudden tragedy. To any clinician who has worked a Nigerian emergency ward, it was a familiar face of the country’s most patient killer – uncontrolled hypertension. When a man has to choose between dinner and school fees, a routine blood pressure check starts to look like a luxury he cannot afford.
Yusuf is not an outlier. He is the pattern. Recent national surveillance puts hypertension at somewhere between 35 and 40 percent of Nigerian adults – and it is no longer a disease that waits for old age. It is cutting down Nigerians in the years they are supposed to be most productive, between 30 and 55. Walk into the neurology wards of our tertiary hospitals and the clinicians will tell you, plainly, that the average age of stroke admission keeps falling, with a disturbing number of patients under 45 arriving with permanent paralysis from blood pressure nobody ever measured. These are breadwinners. They do not just die; they take their households down with them into medical poverty.
So, when the National Assembly passed the historic ₦68.32 trillion 2026 national budget, a cautious sigh of relief moved through parts of the health sector. On paper, the numbers looked serious: a record ₦2.48 trillion for health, the largest health allocation in the country’s history. But for the millions of Nigerians walking around with a silent time bomb in their chests, a trillion-naira headline changes nothing on its own.
